Addex Therapeutics share price logo

Addex Therapeutics

NASDAQ: ADXN

$2.76

-0.26

(-8.61%)

as on

Addex Therapeutics Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.71
    $3.19
    downward going graph

    1.81%

    Downside

    15.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.56
    $11.97
    downward going graph

    7.25%

    Downside

    333.70%

    Upside

    downward going graph

Addex Therapeutics share price movements today

Previous Close
$3.02
Open
$3.09
Volume
181.5K
Market Cap
$5.3M
Day's Low - High
$2.71 - $3.19
52 Week Low - High
$2.56 - $11.97

Addex Therapeutics Historical Returns

1 Month Return
-17.86 %
3 Month Return
-51.54 %
1 Year Return
-74.79 %
3 Year Return
-67.14 %
5 Year Return
-98.38 %

Addex Therapeutics Stock Fundamentals & Key Indicators

Check Addex Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.3M

EPS (TTM)

-5.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.45

Industry PE ratio

-2.36

PEG Ratio

-0.02

EBITDA

-5.7M

Revenue (TTM)

47.6K

Profit Margin

41.19%

Return On Equity TTM

-172.76%

Addex Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Addex Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sell$5.3M-98.38%-0.4541.19%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Addex Therapeutics Stock including INR - Dollar returns

The Addex Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Addex Therapeutics investment value today

Current value as on today

₹27,238

Returns

-₹72,762

(-72.76%)

Returns from Addex Therapeutics Stock

-₹74,795 (-74.79%)

Dollar Impact

₹2,032 (+2.03%)

Analyst Recommendation on Addex Therapeutics Stock

Based on 10 analysts

SELL

10.00%

Buy

20.00%

Hold

70.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'SELL' rating for Addex Therapeutics. Average target price of $30

Addex Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Addex Therapeutics.

What analysts predicted

90.8%UPSIDE

Target Price

$30

Current Price

$2.76

Analyzed by

10 Analysts

Target

$30.00

Addex Therapeutics target price $30, a slight upside of 90.8% compared to current price of $2.76. According to 10 analysts rating.

Indian Investors' Interest in Addex Therapeutics Stock

Search interest for Addex Therapeutics Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-76% versus previous 30 day period

Addex Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
-
0
0
0
Gross Profit
0
0
0
0
0
0
-
0
0
0
Operating Income
-3
0
0
0
0
0
0
0
0
0
EBITDA
-3
0
0
0
0
-1
-1
-1
-1
0
Interest Expense
0
0
0
0
0
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
0
0
0
0
-1
-1
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-2
-2
-2
-3
-1
-1
-1
-1
-1
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%
-369.76%
-153.58%

Addex Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Total Revenue
0
6
2
3
2
1
1
0
0
Gross Profit
0
5
2
3
2
1
1
0
0
Operating Income
-3
-1
-14
-12
-15
-10
-2
-2
-2
EBITDA
-3
-1
-14
-12
-14
-10
-2
-4
-6
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-1
-14
-12
-15
-10
-2
-4
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-3
-1
-14
-12
-15
-20
-10
7
-6
Net Profit Margin
94.05%
97.61%
91.67%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Addex Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-3
-2
-2
-2
-3
-1
-1
-1
-1
-1
Operating Cash Flow
-3
-2
-2
-2
-2
0
0
0
0
0
Investing Cash Flow
0
0
0
0
-
0
-
0
-
-
Financing Cash Flow
0
1
4
0
0
0
0
0
0
0
Change in Cash
-3
-1
1
-2
-2
0
0
0
0
0

Addex Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Net Income
-3
-1
-14
-12
-15
-20
-10
7
-6
Operating Cash Flow
-2
1
-9
-12
-14
-16
-7
-5
-2
Investing Cash Flow
0
0
0
0
0
0
0
4
0
Financing Cash Flow
3
37
0
0
16
3
5
0
1
Change in Cash
1
39
-10
-12
1
-13
-3
0
-1

Global Institutional Holdings in Addex Therapeutics

Check out the Institutions with significant holdings in Addex Therapeutics.

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.03%
UBS Group AG
0.00%
GAMMA Investing LLC
0.01%
SBI Securities Co Ltd
0.00%
Rhumbline Advisers
0.01%

Insights on Addex Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.69K → 9.90K (in $), with an average increase of 22.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 813.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 219.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ADXN stock has moved down by -51.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.71M → -1.73M (in $), with an average decrease of 1.5% per quarter

About Addex Therapeutics

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaboration agreements with significant partners, including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002 and based in Geneva, Switzerland, the company was initially known as Addex Pharmaceuticals Ltd before officially changing its name to Addex Therapeutics Ltd in March 2012.
OrganisationAddex Therapeutics
HeadquartersChemin des Mines, 9, Geneva, GE, 1202, CH
IndustryBiotechnology
CEOTimothy Mark Dyer

Key Management of Addex Therapeutics

Name

Title

Mr. Timothy Mark Dyer

Co-Founder, CEO & Director

Dr. Roger G. Mills M.D.

Chief Medical Officer & Director

Mr. Lénaic Teyssédou

Head of Finance

Dr. Jean-Philippe Rocher Ph.D.

Head of Pharmaceutical Development & Member of Executive Management

FAQs

What is Addex Therapeutics share price today?

Addex Therapeutics share price today is $2.76 as on at the close of the market. Addex Therapeutics share today touched a day high of $3.19 and a low of $2.71.

What is the 52 week high and 52 week low for Addex Therapeutics share?

Addex Therapeutics share touched a 52 week high of $11.97 on and a 52 week low of $2.56 on . Addex Therapeutics stock price today i.e. is closed at $2.76,which is 76.94% down from its 52 week high and 7.81% up from its 52 week low.

What is Addex Therapeutics's market capitalisation today?

Addex Therapeutics market capitalisation is $0.00T as on .

How to invest in Addex Therapeutics Stock (ADXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Addex Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Addex Therapeutics Stock (ADXN) from India?

Indian investors can start investing in Addex Therapeutics (ADXN) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Addex Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Addex Therapeutics share’s latest price of $2.76 as on October 17, 2026 at 8:46 am IST, you will get 3.6232 shares of Addex Therapeutics. Learn more about fractional shares .

What are the returns that Addex Therapeutics has given to Indian investors in the last 5 years?

Addex Therapeutics stock has given -98.38% share price returns and 26.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?